TNF and ankylosing spondylitis: In people with ankylosing spondylitis, previous research has focused on the relationship between body weight and disease outcomes in response to tumor necrosis factor-alpha inhibitors [13], but this limits the study population to those with sufficient disease activity to warrant starting biologic medications.